Accumulated Depreciation Lease AssetsPPE、Compensation For TransferEI、四半期包括利益他3件
- 【期間】
年度 | Accumulated Depreciation Lease AssetsPPE | Compensation For TransferEI | 四半期包括利益 | 当期経常利益 | Research And Development Expenses Research And Development Activities - Life Science Reportable Segment Member | 売上高 - 環境事業 |
---|
2010/09 | - | - | -1.72億 | 59.8億 | - | - |
2011/09 | - | - | 25.5億 黒転 | 56億 -6.2% | - | - |
2012/09 | - | - | -46.7億 赤転 | -19.8億 赤転 | - | - |
2013/09 | - | - | 63.6億 黒転 | 60.9億 黒転 | - | - |
2014/09 | - | - | -791億 赤転 | 82.8億 +35.9% | - | - |
2015/09 | - | - | 19.2億 黒転 | 52.6億 -36.5% | - | - |
2016/09 | - | - | 170億 +782.2% | 145億 +175.7% | - | - |
2017/09 | - | - | 69.4億 -59.1% | 157億 +8.2% | - | - |
2018/09 | - | - | 126億 +81.9% | 155億 -1.4% | - | - |
2019/09 | - | - | 93.6億 -25.9% | 136億 -11.8% | - | - |
2020/09 | - | - | 117億 +25% | 125億 -8.4% | - | 41.3億 |
2021/09 | - | - | 94.5億 -19.2% | 120億 -4% | - | 44.8億 +8.3% |
2022/09 | - | - | 76.1億 -19.5% | 109億 -9.4% | - | 63.4億 +41.5% |
2023/09 | - | - | 113億 +48.8% | 89.6億 -17.6% | - | 43.4億 -31.5% |